|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 December 2000, Vol. 96, No. 13, pp. 4142-4151
HEMATOPOIESIS
Stromal-derived factor 1 and thrombopoietin regulate distinct
aspects of human megakaryopoiesis
Marcin Majka,
Anna Janowska-Wieczorek,
Janina Ratajczak,
M. Anna Kowalska,
Gaston Vilaire,
Zhixing K. Pan,
Marek Honczarenko,
Leah A. Marquez,
Mortimer Poncz, and
Mariusz Z. Ratajczak
From the Department of Pathology and Laboratory
Medicine and the Department of Pediatrics, University of Pennsylvania
School of Medicine, Philadelphia, PA; the Department of Medicine,
University of Alberta, and Canadian Blood Services, Edmonton, Alberta,
Canada; and the Department of Molecular and Experimental Medicine, The
Scripps Research Institute, La Jolla, CA.
The role of the chemokine binding stromal-derived factor 1 (SDF-1)
in normal human megakaryopoiesis at the cellular and molecular levels
and its comparison with that of thrombopoietin (TPO) have not been
determined. In this study it was found that SDF-1, unlike TPO, does not
stimulate  IIb 3+ cell
proliferation or differentiation or have an antiapoptotic effect.
However, it does induce chemotaxis, trans-Matrigel migration, and secretion of matrix metalloproteinase 9 (MMP-9) and vascular endothelial growth factor (VEGF) by these cells, and both SDF-1 and TPO
increase the adhesion of
IIb3+ cells to fibrinogen and
vitronectin. Investigating the intracellular signaling pathways induced
by SDF-1 and TPO revealed some overlapping patterns of protein
phosphorylation/activation (mitogen-activated protein kinase [MAPK]
p42/44, MAPK p38, and AKT [protein kinase B]) and some that were
distinct for TPO (eg, JAK-STAT) and for SDF-1 (eg, NF- B). It was
also found that though inhibition of phosphatidyl-inositol 3-kinase
(PI-3K) by LY294002 in
IIb3+ cells induced apoptosis
and inhibited chemotaxis adhesion and the secretion of MMP-9 and VEGF,
the inhibition of MAPK p42/44 (by the MEK inhibitor U0126) had no
effect on the survival, proliferation, and migration of these cells.
Hence, it is suggested that the proliferative effect of TPO is more
related to activation of the JAK-STAT pathway (unique to TPO), and the
PI-3K-AKT axis is differentially involved in TPO- and SDF-1-dependent
signaling. Accordingly, PI-3K is involved in TPO-mediated inhibition of
apoptosis, TPO- and SDF-1-regulated adhesion to fibrinogen and
vitronectin, and SDF-1-mediated migration. This study expands the
understanding of the role of SDF-1 and TPO in normal human
megakaryopoiesis and indicates the molecular basis of the observed
differences in cellular responses.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. P. Lambert, Y. Wang, K. H. Bdeir, Y. Nguyen, M. A. Kowalska, and M. Poncz
Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes
Blood,
September 10, 2009;
114(11):
2290 - 2298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Scupoli, M. Donadelli, F. Cioffi, M. Rossi, O. Perbellini, G. Malpeli, S. Corbioli, F. Vinante, M. Krampera, M. Palmieri, et al.
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-{kappa}B and JNK/AP-1 pathways
Haematologica,
April 1, 2008;
93(4):
524 - 532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Freson, K. Peeters, R. De Vos, C. Wittevrongel, C. Thys, M. F. Hoylaerts, J. Vermylen, and C. Van Geet
PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications
Blood,
February 15, 2008;
111(4):
1885 - 1893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Q. Dai, X.-J. Zhu, F.-Q. Liu, J.-H. Xiang, H. Nagasawa, and W.-J. Yang
Involvement of p90 Ribosomal S6 Kinase in Termination of Cell Cycle Arrest during Development of Artemia-encysted Embryos
J. Biol. Chem.,
January 18, 2008;
283(3):
1705 - 1712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Pasha, Y. Wang, R. Sheikh, D. Zhang, T. Zhao, and M. Ashraf
Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium
Cardiovasc Res,
January 1, 2008;
77(1):
134 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Lambert, L. Rauova, M. Bailey, M. C. Sola-Visner, M. A. Kowalska, and M. Poncz
Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications
Blood,
August 15, 2007;
110(4):
1153 - 1160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yoon, Z. Liang, X. Zhang, M. Choe, A. Zhu, H. T. Cho, D. M. Shin, M. M. Goodman, Z. Chen, and H. Shim
CXC Chemokine Receptor-4 Antagonist Blocks Both Growth of Primary Tumor and Metastasis of Head and Neck Cancer in Xenograft Mouse Models
Cancer Res.,
August 1, 2007;
67(15):
7518 - 7524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Raslova, V. Baccini, L. Loussaief, B. Comba, J. Larghero, N. Debili, and W. Vainchenker
Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation
Blood,
March 15, 2006;
107(6):
2303 - 2310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Gallego, M. A. de la Fuente, I. M. Anton, S. Snapper, R. Fuhlbrigge, and R. S. Geha
WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1{alpha}
Int. Immunol.,
February 1, 2006;
18(2):
221 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Z. Ratajczak
RGS16 "tightens the reins" on CXCR4
Blood,
November 1, 2005;
106(9):
2928 - 2929.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nishio, T. Endo, N. Tsukada, J. Ohata, S. Kitada, J. C. Reed, N. J. Zvaifler, and T. J. Kipps
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1{alpha}
Blood,
August 1, 2005;
106(3):
1012 - 1020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Moriguchi, B. D. Hissong, M. Gadina, K. Yamaoka, H. L. Tiffany, P. M. Murphy, F. Candotti, and J. J. O'Shea
CXCL12 Signaling Is Independent of Jak2 and Jak3
J. Biol. Chem.,
April 29, 2005;
280(17):
17408 - 17414.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Wysoczynski, R. Reca, J. Ratajczak, M. Kucia, N. Shirvaikar, M. Honczarenko, M. Mills, J. Wanzeck, A. Janowska-Wieczorek, and M. Z. Ratajczak
Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient
Blood,
January 1, 2005;
105(1):
40 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Jaleel, A. C. Tsai, S. Sarkar, P. V. Freedman, and L. P. Rubin
Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival
Mol. Hum. Reprod.,
December 1, 2004;
10(12):
901 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-M. Paulus, N. Debili, F. Larbret, J. Levin, and W. Vainchenker
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors
Blood,
October 15, 2004;
104(8):
2291 - 2298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ratajczak, R. Reca, M. Kucia, M. Majka, D. J. Allendorf, J. T. Baran, A. Janowska-Wieczorek, R. A. Wetsel, G. D. Ross, and M. Z. Ratajczak
Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow
Blood,
March 15, 2004;
103(6):
2071 - 2078.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Jankowski, M. Kucia, M. Wysoczynski, R. Reca, D. Zhao, E. Trzyna, J. Trent, S. Peiper, M. Zembala, J. Ratajczak, et al.
Both Hepatocyte Growth Factor (HGF) and Stromal-Derived Factor-1 Regulate the Metastatic Behavior of Human Rhabdomyosarcoma Cells, But Only HGF Enhances Their Resistance to Radiochemotherapy
Cancer Res.,
November 15, 2003;
63(22):
7926 - 7935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Reca, D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L. A. Spruce, A. Janowska-Wieczorek, et al.
Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1
Blood,
May 15, 2003;
101(10):
3784 - 3793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Libura, J. Drukala, M. Majka, O. Tomescu, J. M. Navenot, M. Kucia, L. Marquez, S. C. Peiper, F. G. Barr, A. Janowska-Wieczorek, et al.
CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion
Blood,
September 18, 2002;
100(7):
2597 - 2606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Lee, A. Gotoh, H.-J. Kwon, M. You, L. Kohli, C. Mantel, S. Cooper, G. Hangoc, K. Miyazawa, K. Ohyashiki, et al.
Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines
Blood,
May 29, 2002;
99(12):
4307 - 4317.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-J. Lataillade, D. Clay, P. Bourin, F. Herodin, C. Dupuy, C. Jasmin, and M.-C. Le Bousse-Kerdiles
Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism
Blood,
February 15, 2002;
99(4):
1117 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Cristillo and B. E. Bierer
Identification of Novel Targets of Immunosuppressive Agents by cDNA-based Microarray Analysis
J. Biol. Chem.,
February 1, 2002;
277(6):
4465 - 4476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Millot, W. Vainchenker, D. Dumenil, and F. Svinarchuk
Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells
J. Cell Sci.,
January 6, 2002;
115(11):
2329 - 2337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Janowska-Wieczorek, M. Majka, J. Kijowski, M. Baj-Krzyworzeka, R. Reca, A. R. Turner, J. Ratajczak, S. G. Emerson, M. A. Kowalska, and M. Z. Ratajczak
Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment
Blood,
November 15, 2001;
98(10):
3143 - 3149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Thelen and M. Baggiolini
Is Dimerization Of Chemokine Receptors Functionally Relevant?
Sci. Signal.,
October 16, 2001;
2001(104):
pe34 - pe34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. KIM, S. KIM, H. KOH, S.-O. YOON, A.-S. CHUNG, K. S. CHO, and J. CHUNG
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
FASEB J,
September 1, 2001;
15(11):
1953 - 1962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B.-S. Youn, Y. J. Kim, C. Mantel, K.-Y. Yu, and H. E. Broxmeyer
Blocking of c-FLIPL-independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction
Blood,
August 15, 2001;
98(4):
925 - 933.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. K. Sen, S. Khanna, M. Venojarvi, P. Trikha, E. C. Ellison, T. K. Hunt, and S. Roy
Copper-induced vascular endothelial growth factor expression and wound healing
Am J Physiol Heart Circ Physiol,
May 1, 2002;
282(5):
H1821 - H1827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
